Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1

2024-9-11

Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome

2024-9-11

Asymptomatic Bloom syndrome diagnosed by chance in a patient with breast cancer

2024-9-6

A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome

2024-9-5

Complications of colonoscopy surveillance of patients with Lynch syndrome – 33 years of follow up

2024-8-5

Colonoscopic surveillance in Lynch syndrome: guidelines in perspective

2024-7-27

Endoscopic indicators in patients with familial adenomatous polyposis undergoing duodenal resections – a nationwide Danish cohort study with long-term follow-up

2024-7-24

Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022

2024-7-20

Correction: Clinician perspectives on policy approaches to genetic risk disclosure in families

2024-7-9

Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery

2024-7-1

Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy

2024-6-21

Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia

2024-6-21

Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report

2024-6-20

Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients

2024-6-20

The 17th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC)

2024-6-18

In memoriam: Gloria Petersen, PhD (1950-2023)

2024-6-13

Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort

2024-6-7

Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue

2024-6-6

Somatic STK11 mosaicism in a Turkish patient with Peutz-Jeghers syndrome

2024-6-1

Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant

2024-6-1

A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

2024-6-1

Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow

2024-5-29

Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer

2024-5-25

Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia

2024-5-25

The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants

2024-5-23

A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis

2024-5-19

The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer

2024-5-16

Cascade genetic testing: an underutilized pathway to equitable cancer care?

2024-5-15

Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent

2024-5-14

Expanding access to genetic testing for pancreatic cancer

2024-5-11

Familial and hereditary pancreatic cancer in Japan

2024-5-11

The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review

2024-5-11

Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions

2024-5-11

Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives

2024-5-9

A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America

2024-4-30

Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family

2024-4-30

Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study

2024-4-30

Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review

2024-4-25

The role of biomarkers in the early detection of pancreatic cancer

2024-4-25

Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy

2024-4-25

Surgical aspects related to hereditary pancreatic cancer

2024-4-25

The odyssee from surveillance to the detection of pancreatic cancer, total pancreatectomy, and its impact on life. insights from a p16-Leiden pathogenic variant carrier

2024-4-25

Clinical features of prostate cancer by polygenic risk score

2024-4-15

Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer

2024-4-15

Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women

2024-4-12

Evaluation of EGFR and COX pathway inhibition in human colon organoids of serrated polyposis and other hereditary cancer syndromes

2024-4-12

Understanding familial risk of pancreatic ductal adenocarcinoma

2024-4-12

The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals

2024-4-4

Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)

2024-4-4

Editorial for familial cancer: cascade genetic testing

2024-4-1